Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1

Conditions

Precancerous Conditions 6Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoldering Multiple Myeloma 1Rectal Neoplasms 1Papillomavirus Infections 1Oropharyngeal Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Liver Neoplasms 1Leukoplakia, Oral 1Infections 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1Anus Neoplasms 1Adenomatous Polyps 1

Interventions

Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4fludarabine phosphate 3Epoetin Alfa 3Darbepoetin alfa 3Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Morphine 2Microarray Analysis 2Methylprednisolone 2Interferon-alpha 2In Situ Hybridization, Fluorescence 2Filgrastim 2Cytogenetic Analysis 2Cyclosporine 2Carboplatin 2Busulfan 2Antilymphocyte Serum 2tanespimycin 1sargramostim 1pyroxamide 1ferrous sulfate 1ferric gluconate 1alethine 1aldesleukin 1Topotecan 1Therapeutics 1Tetradecanoylphorbol Acetate 1Sucrose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Monoclonal Gammopathy of Undetermined Significance × Gene Expression Profiling × Other neoplasm × Clear all
NCT00942422 2015-03-27

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Barbara Ann Karmanos Cancer Institute

Phase 2 Terminated
8 enrolled 5 charts
Other neoplasmPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡